Switch to:
More From Other Websites
Pain Therapeutics (PTIE) Enters Oversold Territory Sep 29 2016
Pain Therapeutics (PTIE) Down on CRL for Chronic Pain Drug Sep 28 2016
Austin drugmaker's stock falters after latest FDA rejection Sep 27 2016
Durect Corp. (DRRX) Stock Tumbles on FDA Opioid Analgesic Drug Rejection Sep 26 2016
5 Big-Volume Stocks You Should Stay Away From -- Plus 2 to Buy Sep 26 2016
GW Pharmaceuticals (GWPH), Sally Beauty Holdings Inc. (SBH) & More: Why These Stocks Are Making... Sep 26 2016
For Pain Therapeutics CEO, 3 FDA Rejections Are Worth $23 Million Sep 26 2016
Is Pain Therapeutics an Incredible Momentum Stock? 3 Reasons Why PTIE Will Be Tough to Beat Sep 26 2016
Get ready. One of tech’s biggest darlings is in for a bumpy ride Sep 26 2016
Pain Therapeutics receives FDA letter saying NDA for opioid analgesic can't be approved Sep 26 2016
Complete Response Letter for REMOXY® Sep 26 2016
DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER... Sep 26 2016
PAIN THERAPEUTICS INC Files SEC form 8-K, Other Events Sep 26 2016
Complete Response Letter for REMOXY® Sep 26 2016
Will Pain Therapeutics (PTIE) Continue to Surge Higher? Sep 23 2016
Pain Therapeutics downgraded by Gabelli & Co Sep 13 2016
PAIN THERAPEUTICS INC Financials Jul 23 2016
Pain Therapeutics (PTIE) Worth a Look: Stock Gains 7.6% Jul 22 2016
Pain Therapeutics reports 2Q loss Jul 19 2016
Pain Therapeutics reports 2Q loss Jul 19 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK